{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:04:16Z","timestamp":1782144256863,"version":"3.54.5"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neur Clin Pract"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1212\/cpj.0b013e3182a78ecf","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T20:02:43Z","timestamp":1381780963000},"page":"440-445","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Intravenous immunoglobulin for treatment of neuromuscular disease"],"prefix":"10.1212","volume":"3","author":[{"given":"Katherine","family":"Ruzhansky","sequence":"first","affiliation":[{"name":"Peripheral Neuropathy Center, Neurological Institute, Columbia University, College of Physicians and Surgeons, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Thomas H.","family":"Brannagan","sequence":"additional","affiliation":[{"name":"Peripheral Neuropathy Center, Neurological Institute, Columbia University, College of Physicians and Surgeons, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.12_suppl_6.S33"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21277"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0807319106"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-3002-0"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70329-0"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(97)00292-X"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21433"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821e5505"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.04.002"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-0969-0"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cnd.0000205575.26451.e4"},{"key":"e_1_3_1_13_2","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barre syndrome","volume":"7","author":"Hughes RA","year":"2012","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev 2012;7:CD002063.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Neurology Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/CPJ.0b013e3182a78ecf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T16:59:18Z","timestamp":1711558758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/CPJ.0b013e3182a78ecf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1212\/CPJ.0b013e3182a78ecf"],"URL":"https:\/\/doi.org\/10.1212\/cpj.0b013e3182a78ecf","relation":{},"ISSN":["2163-0402","2163-0933"],"issn-type":[{"value":"2163-0402","type":"print"},{"value":"2163-0933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}